Fimecsincis Developing A New Class Of Drugs Based On Targeted Protein Degradation For Thecurrently Ae Undruggabletargets In Immuno Oncology And Oncology Areasthecompany Becameableto Discover Drug Candidates For Inducing Thedegradation Of Diseaserelevant Targeted Proteins By Integrating Proprietary E Ligasebinders And Rappidsa C Platformthis Drug Discovery Platform Will Help Providing Drugs To Thepatients All Over Theworld Through Various Internal And Collaboration Projects
| Company Name | Fimecs Inc |
| Country |
Japan
|
| Address | N/A |
| Telephone | N/A |
| N/A |
United States